Surgery Partners, Inc. (NASDAQ: SGRY) reported Q3 EPS of ($0.02), $0.07 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $620.6 million versus the consensus estimate of $634.98 million.

GUIDANCE:

Surgery Partners, Inc. sees FY2022 revenue of $2.5-2.55 billion, versus the consensus of $2.54 billion.

• reaffirms projected 2022 Adjusted EBITDA of $375 million to $385 million

For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.